兰州生物制品研究所有限责任公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
100
NMPA:100
Drug Approvals
Reassortant Rotavirus Vaccine, live, Oral, Trivalent (Vero Cell)
- Product Name
- 瑞特威
- Approval Number
- 国药准字S20230022
- Approval Date
- Apr 17, 2023
NMPA
Typhoid and Para-typhoid A & B Combined Vaccine
- Product Name
- 伤寒、副伤寒甲、乙联合疫苗
- Approval Number
- 国药准字S10820144
- Approval Date
- Jun 22, 2020
NMPA
Recombinant Hepatitis B Vaccine(CHO Cell)
- Product Name
- 重组乙型肝炎疫苗(CHO细胞)
- Approval Number
- 国药准字S19983014
- Approval Date
- Jun 22, 2020
NMPA
Japanese Encephalitis Purified Vaccine,(PHK cell)
- Product Name
- 乙型脑炎纯化疫苗(地鼠肾细胞)
- Approval Number
- 国药准字S20060058
- Approval Date
- Jun 22, 2020
NMPA
RHaemorrhagic Fever with Renal Syndrome Bivalent Purified Vaccine (Vero cell)
- Product Name
- 双价肾综合征出血热纯化疫苗(Vero细胞)
- Approval Number
- 国药准字S20050109
- Approval Date
- Jun 22, 2020
NMPA
Recombinant Hepatitis B Vaccine(CHO Cell)
- Product Name
- 重组乙型肝炎疫苗(CHO细胞)
- Approval Number
- 国药准字S20033007
- Approval Date
- Jun 22, 2020
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 10
- Next
Clinical Trials
No trials found
News
No news found